As unusual as it may seem for some people, sometimes indicators of diseases may lie in what we flush out of our bodies, like our stools. The color may be an indicator of something as serious as stomach cancer.
One of the types of cancer that plague a portion of the world’s population is stomach cancer. While it is not as prevalent as the other types such as lung cancer, it is still serious and must be treated before it gets worse. Express reports that an indicator that a person may have the disease is in the color of the stool. The color of the stool usually indicates how healthy a person is, and in this case, if the stool is very dark, almost black in color, then it may be a symptom of stomach cancer.
Then again, the color of the stool may also be affected by the medication being taken as well as the kind of food or drinks being eaten. According to Cancer Research UK, a person’s stool may also be the same dark, almost-black color if they take iron tablets.
At the same time, blood in the stool may also indicate the disease. However, as with any illness, these symptoms may be indicators for other diseases so it is still best to check with a physician, who can give a proper test. The symptoms of stomach cancer may also overlap with symptoms of stomach ulcers or other conditions that may not be as serious.
Meanwhile, there are kinds of food that do affect the color of the stools. Seeing a different color may seem alarming but before the panic sets in, it is also good to think about what kind of food you may have eaten. Beets may affect the color of the stool and turn it into a dark red color, almost like blood.
In case the stool in the toilet is of a greenish hue, then veggies are the likely cause. Green stools are usually harmless and do not really indicate serious issues, such as diarrhea, salmonella infections, and stomach cramps. Blueberries may also be the cause of a blueish tinge in the stool.


Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 



